The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease

被引：424
|
作者：
Cookson, Mark R. [1 ]
机构：
[1] NIA, Neurogenet Lab, NIH, Bethesda, MD 20982 USA
来源：
NATURE REVIEWS NEUROSCIENCE | 2010年 / 11卷 / 12期
基金：
美国国家卫生研究院;
关键词：
AUTOSOMAL-DOMINANT PARKINSONISM; ALPHA-SYNUCLEIN; LEUCINE-RICH-REPEAT-KINASE-2; LRRK2; CYTOPLASMIC LOCALIZATION; 14-3-3; BINDING; ROC DOMAIN; MUTATIONS; PROTEIN; PHOSPHORYLATION; GENE;
D O I：
10.1038/nrn2935
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Parkinson's disease, like many common age-related conditions, is now recognized to have a substantial genetic component. Here, I discuss how mutations in a large complex gene-leucine-rich repeat kinase 2 (LRRK2) - affect protein function, and I review recent evidence that LRRK2 mutations affect pathways that involve other proteins that have been implicated in Parkinson's disease, specifically a-synuclein and tau. These concepts can be used to understand disease processes and to develop therapeutic opportunities for the treatment of Parkinson's disease.
引用
收藏
页码：791 / 797
页数：7
相关论文
共 50 条
  • [31] Function of LRRK2 in Parkinson's Disease
    Zhu Fei-Zhou
    Xia Kun
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2010, 37 (10) : 1059 - 1066
  • [32] The Parkinson's disease-linked Leucine-rich repeat kinase 2 (LRRK2) is required for insulin-stimulated translocation of GLUT4
    Funk, Natalja
    Munz, Marita
    Ott, Thomas
    Brockmann, Kathrin
    Wenninger-Weinzierl, Andrea
    Kuehn, Ralf
    Vogt-Weisenhorn, Daniela
    Giesert, Florian
    Wurst, Wolfgang
    Gasser, Thomas
    Biskup, Saskia
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [33] Advances in elucidating the function of leucine-rich repeat protein kinase-2 in normal cells and Parkinson's disease
    Taylor, Matthew
    Alessi, Dario R.
    CURRENT OPINION IN CELL BIOLOGY, 2020, 63 : 102 - 113
  • [34] Potent, selective and orally bioavailable leucine-rich repeat kinase 2 (LRRK2) inhibitors
    Greshock, Thomas J.
    Sanders, John M.
    Drolet, Robert E.
    Rajapakse, Hemaka A.
    Chang, Ronald K.
    Kim, Boyoung
    Rada, Vanessa L.
    Tiscia, Heather E.
    Su, Hua
    Lai, Ming-Tain
    Sur, Sylvie M.
    Sanchez, Rosa I.
    Bilodeau, Mark T.
    Renger, John J.
    Kern, Jonathan T.
    McCauley, John A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (11) : 2631 - 2635
  • [35] Leucine-Rich Repeat Kinase 2 (LRRK2)-Deficient Rats Exhibit Renal Tubule Injury and Perturbations in Metabolic and Immunological Homeostasis
    Ness, Daniel
    Ren, Zhao
    Gardai, Shyra
    Sharpnack, Douglas
    Johnson, Victor J.
    Brennan, Richard J.
    Brigham, Elizabeth F.
    Olaharski, Andrew J.
    PLOS ONE, 2013, 8 (06):
  • [36] A QUICK Screen for Lrrk2 Interaction Partners - Leucine-rich Repeat Kinase 2 is Involved in Actin Cytoskeleton Dynamics
    Meixner, Andrea
    Boldt, Karsten
    Van Troys, Marleen
    Askenazi, Manor
    Gloeckner, Christian J.
    Bauer, Matthias
    Marto, Jarrod A.
    Ampe, Christophe
    Kinkl, Norbert
    Ueffing, Marius
    MOLECULAR & CELLULAR PROTEOMICS, 2011, 10 (01)
  • [37] Cerebrospinal Fluid Biomarkers and Clinical Features in Leucine-Rich Repeat Kinase 2 (LRRK2) Mutation Carriers
    Vilas, Dolores
    Shaw, Leslie M.
    Taylor, Peggy
    Berg, Daniela
    Brockmann, Kathrin
    Aasly, Jan
    Marras, Connie
    Pont-Sunyer, Claustre
    Rios, Jose
    Marek, Ken
    Tolosa, Eduardo
    MOVEMENT DISORDERS, 2016, 31 (06) : 906 - 914
  • [38] Leucine-rich repeat kinase 2 and alpha-synuclein: intersecting pathways in the pathogenesis of Parkinson's disease?
    Greggio, Elisa
    Bisaglia, Marco
    Civiero, Laura
    Bubacco, Luigi
    MOLECULAR NEURODEGENERATION, 2011, 6
  • [39] Role of LRRK2 kinase dysfunction in Parkinson disease
    Kumar, Azad
    Cookson, Mark R.
    EXPERT REVIEWS IN MOLECULAR MEDICINE, 2011, 13 : e20
  • [40] Role of LRRK2 kinase activity in the pathogenesis of Parkinson's disease
    Greggio, Elisa
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2012, 40 : 1058 - 1062
12345